Celebrating Over Ten Years of Success in Healthcare
We are excited to celebrate over a decade of remarkable growth and success at Revelation Partners—made possible by the enduring partnership and support of our limited partners, trusted counterparties, and friends of the firm. Over the past ten years, our team and platform have expanded significantly, and we are deeply grateful to everyone who has […]
Bluejay Capital Partners Recapitalizes Quality Life Science Logistics & Transportation
DENVER & COOPERSVILLE, Mich., December 02, 2025–(BUSINESS WIRE)–Bluejay Capital Partners, LLC (Bluejay Capital), a specialist in partnering and investing in transportation and logistics businesses, has recapitalized Quality Life Science Logistics & Transportation (QLS), a premier provider of specialized cold chain transportation and logistics solutions for the pharmaceutical and life sciences industries. Terms of the transaction were not disclosed. […]
Aspen enriches Parkinson’s cell therapy trial with Kite-backed $115M series C
Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ongoing trial of a regenerative cell therapy for Parkinson’s disease. The raise will power Aspen’s phase 1/2 study of ANPD001, a therapy that turns patients’ skin cells into new neurons that are then transplanted into their brains to […]
Healthcare-Focused Secondaries Manager Revelation Partners Expands Investment Team, Promotes Eric Shiozaki to Partner
Revelation Partners, a leading investment manager in the healthcare secondaries market, today announced the appointment of Eric Shiozaki, Ph.D. as a partner. Shiozaki joined the firm in 2024 as a venture partner and focuses on investment opportunities in biotech and medical devices. Sausalito, Calif.-based Revelation Partners manages more than $1.5 billion in committed capital and provides liquidity […]
Five Takeaways on the State of AI in Healthcare from HLTH 2025
Healthcare’s AI Moment is Here—and it’s Operational HLTH 2025 made one thing unmistakably clear: healthcare’s AI era is no longer about pilots or prototypes—it’s about productivity. Across every panel and conversation, the message was the same: AI is moving from concept to infrastructure. Clinicians, executives, and investors agreed that the technology’s value is finally being […]
Betting on the Backbone: Investing in Payer IT
Healthcare insurers sit at the center of the U.S. healthcare system, controlling nearly 90 cents of every healthcare dollar[1]. Yet despite their scale and influence, the nation’s largest payers (e.g. Humana, CVS, UnitedHealthcare, etc.) are facing unprecedented pressure. Stock prices for the major insurers have dropped 15–55% since early 2023, even as the overall market […]
Unlocking Capital to Keep Healthcare GPs in the Game
In this white paper, we cover:
Omada Health Reports Second Quarter 2025 Results
Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the second quarter ended June 30, 2025. “I’m proud of our second quarter results, with 49% year-over-year revenue growth, strong margin improvements, and continued progress toward profitability,” said Sean Duffy, Co-founder and CEO of Omada Health. “We believe our Q2 performance […]
Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia
Boehringer Ingelheim and Click Therapeutics today announced that the pivotal Phase III CONVOKE study (NCT05838625) of CT-155 (BI 3972080), an investigational prescription digital therapeutic (PDT), met its primary endpoint. The randomized, double-blind, controlled study investigated the effectiveness and safety of CT-155 versus a digital control app as an adjunct to standard of care antipsychotic therapy […]
Healthcare-Focused Secondaries Manager Revelation Partners Names Rob Rein as Principal and Courtney Munley and Vicky Valverde as Senior Associates
Revelation Partners, a secondaries investor focused exclusively on the private healthcare market, today announced that Rob Rein has been named principal and Courtney Munley and Vicky Valverde have been named senior associates. Rein joined Revelation Partners in June 2023 as a vice president and helps drive the firm’s sourcing and transaction execution efforts. He has supported multiple transactions that provided liquidity to […]